Diakos, C. I., Charles, K. A., McMillan, D. C. & Clarke, S. J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15, e493–e503 (2014).

PubMed  Google Scholar 

Kumar, S. K. et al. Multiple myeloma. Nat. Rev. Dis. Prim. 3, 17046 (2017).

PubMed  Google Scholar 

Kawano, Y. et al. Targeting the bone marrow microenvironment in multiple myeloma. Immunol. Rev. 263, 160–172 (2015).

PubMed  Google Scholar 

de Jong, M. M. E. et al. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat. Immunol. 22, 769–780 (2021).

PubMed  Google Scholar 

Liu, Q. et al. The CXCL8–CXCR1/2 pathways in cancer. Cytokine Growth Factor Rev. 31, 61–71 (2016).

PubMed  PubMed Central  Google Scholar 

Wright, H. L., Cross, A. L., Edwards, S. W. & Moots, R. J. Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo. Rheumatology 53, 1321–1331 (2014).

CAS  PubMed  Google Scholar 

Zheng, Z. et al. Lung mesenchymal stromal cells influenced by TH2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3. Nat. Commun. 12, 6202 (2021).

PubMed  PubMed Central  Google Scholar 

Shaul, M. E. & Fridlender, Z. G. Tumour-associated neutrophils in patients with cancer. Nat. Rev. Clin. Oncol. 16, 601–620 (2019).

PubMed  Google Scholar 

Hedrick, C. C. & Malanchi, I. Neutrophils in cancer: heterogeneous and multifaceted. Nat. Rev. Immunol. 22, 173–187 (2022).

CAS  PubMed  Google Scholar 

Shen, M. et al. Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS ONE 9, e98259 (2014).

PubMed  PubMed Central  Google Scholar 

Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst. 106, dju124 (2014).

PubMed  Google Scholar 

Coffelt, S. B. et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348 (2015).

CAS  PubMed  PubMed Central  Google Scholar 

Sagiv, J. Y. et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 10, 562–573 (2015).

CAS  PubMed  Google Scholar 

Furze, R. C. & Rankin, S. M. Neutrophil mobilization and clearance in the bone marrow. Immunology 125, 281–288 (2008).

CAS  PubMed  PubMed Central  Google Scholar 

Sender, R. et al. The total mass, number, and distribution of immune cells in the human body. Proc. Natl Acad. Sci. USA 120, e2308511120 (2023).

CAS  PubMed  PubMed Central  Google Scholar 

Botta, C., Gullà, A., Correale, P., Tagliaferri, P. & Tassone, P. Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities. Front. Oncol. 4, 348 (2014).

PubMed  PubMed Central  Google Scholar 

Perez, C. et al. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma. Blood 136, 199–209 (2020).

PubMed  Google Scholar 

Romano, A. et al. High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling. Sci. Rep. 10, 1983 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Szudy-Szczyrek, A. et al. Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen. Ann. Hematol. 99, 2881–2891 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Shi, L. et al. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget 8, 18792–18801 (2017).

PubMed  Google Scholar 

Giallongo, C. et al. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma. Cell Death Dis. 10, 704 (2019).

PubMed  PubMed Central  Google Scholar 

Dimitrov, D. et al. Comparison of methods and resources for cell–cell communication inference from single-cell RNA-seq data. Nat. Commun. 13, 3224 (2022).

PubMed  PubMed Central  Google Scholar 

Jia, S. H. et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113, 1318–1327 (2004).

CAS  PubMed  PubMed Central  Google Scholar 

Venkateshaiah, S. U. et al. NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Exp. Hematol. 41, 547–557 (2013).

CAS  PubMed  PubMed Central  Google Scholar 

Managò, A. et al. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation. Nat. Commun. 10, 4116 (2019).

PubMed  PubMed Central  Google Scholar 

Hengeveld, P. J. & Kersten, M. J. B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? Blood Cancer J. 5, e282 (2015).

CAS  PubMed  PubMed Central  Google Scholar 

Bossen, C. & Schneider, P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18, 263–275 (2006).

CAS  PubMed  Google Scholar 

Shah, N., Chari, A., Scott, E., Mezzi, K. & Usmani, S. Z. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia 34, 985–1005 (2020).

PubMed  PubMed Central  Google Scholar 

Hamarsheh, S. A. & Zeiser, R. NLRP3 inflammasome activation in cancer: a double-edged sword. Front. Immunol. 11, 1444 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Yang, Y., Wang, H., Kouadir, M., Song, H. & Shi, F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 10, 128 (2019).

PubMed  PubMed Central  Google Scholar 

Lust, J. A. et al. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1β-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin. Proc. 84, 114–122 (2009).

CAS  PubMed  PubMed Central  Google Scholar 

Hofbauer, D. et al. β2-Microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity 54, 1772–1787 (2021).

CAS  PubMed  Google Scholar 

Tong, D. et al. The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer Metastasis Rev. 37, 355–368 (2018).

CAS  PubMed  Google Scholar 

Munder, M. et al. Suppression of T-cell functions by human granulocyte arginase. Blood 108, 1627–1634 (2006).

CAS  PubMed  Google Scholar 

Fragioudaki, M. et al. Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma. Leuk. Res. 36, 1004–1008 (2012).

CAS  PubMed  Google Scholar 

Moreaux, J. R. M. et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103, 3148–3157 (2004).

CAS  PubMed  Google Scholar 

Busch, K. et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 518, 542–546 (2015).

CAS  PubMed  Google Scholar 

Schäffler, A. & Büchler, C. Adipose tissue-derived stromal cells—basic and clinical implications for novel cell-based therapies. Stem Cells 25, 818–827 (2007).

PubMed  Google Scholar 

Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13, 1235–1242 (2006).

CAS  PubMed  Google Scholar 

Friščić, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002–1021 (2021).

PubMed  Google Scholar 

Molejon, M. I. et al. Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma. Oncotarget 6, 7408–7423 (2015).

PubMed  PubMed Central  Google Scholar 

Yang, C. et al. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas. Oncogene 38, 7113–7132 (2019).

CAS  PubMed  Google Scholar 

Owattanapanich, W., Suphadirekkul, K., Kunacheewa, C., Ungprasert, P. & Prayongratana, K. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis. BMC Cancer 18, 1126 (2018).

CAS  PubMed  PubMed Central  Google Scholar 

Lemancewicz, D. et al. Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features. Leuk. Res. 37, 1089–1093 (2013).

CAS  PubMed  Google Scholar 

Yu, P. F. et al. TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene 36, 482–490 (2017).

CAS  PubMed